Citigroup’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
CFM
VP
VCM
MA
BFM
Citigroup's MXCT Position: Q1 2026 in Review
Citigroup reduced its MaxCyte (MXCT) stake by 86% in Q1 2026, selling an estimated $29.2K and leaving 5,147 shares worth $3.62K. The position accounts for ﹤0.01% of the portfolio, ranked #5331.
Citigroup first reported a position in MXCT in Q3 2021 and has held it in 19 quarters since. The position peaked at $6.3M in Q2 2022. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.
- Citigroup held 5,147 shares of MaxCyte worth $3.62K as of Q1 2026.
- Citigroup sold 31,262 MaxCyte shares in Q1 2026, an estimated $29.2K.
- MaxCyte made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5331 holding.
- Citigroup first reported a position in MaxCyte in Q3 2021 and has held it in 19 quarters since.
- Citigroup's MaxCyte position peaked at $6.3M in Q2 2022.
- 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.